Ind-Swift Laboratories Ltd (INDSWFTLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 393806, "name": "Ind-Swift Labs.", "stock_name": "Ind-Swift Labs.", "full_name": "Ind-Swift Laboratories Ltd", "name_url": "stocks-analysis/ind-swift-labs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "136.30", "chg": 4.7, "chgp": "3.57%", "dir": 1, "prev_price": "131.60", "mcapval": "1,112.37 Cr", "mcap": "Micro Cap", "scripcode": 532305, "symbol": "INDSWFTLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE915B01019", "curr_date": "Apr 01", "curr_time": "", "bse_nse_vol": "3.55 lacs", "exc_status": "Active", "traded_date": "Apr 01, 2026", "traded_date_str": "2026 04 01", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Ind-Swift Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-3928203", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_mojoScore_3928203.png", "date": "2026-04-01 10:10:44", "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance." }, { "title": "Ind-Swift Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-3904867", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_mojoScore_3904867.png", "date": "2026-03-21 10:10:25", "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 March 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Ind-Swift Laboratories Declines 5.67%: Mixed Signals and Downgrade Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-declines-567-mixed-signals-and-downgrade-shape-the-week-3891989", "imagepath": "", "date": "2026-03-15 10:01:32", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Stock drops 5.78% amid broad market weakness</p>\n <p><strong>4 Mar:</strong> Further decline of 8.03% on low volume</p>\n <p><strong>5 Mar:</strong> Sharp rebound with 8.93% gain supported by technical momentum</p>\n <p><strong>6 Mar:</strong> Downgrade to Sell and mixed technical signals weigh on price, closing near Rs.137.20</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.145.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..." }, { "title": "Ind-Swift Laboratories Gains 0.18%: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-gains-018-2-key-factors-driving-the-week-3891322", "imagepath": "", "date": "2026-03-14 15:03:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>09 Mar:</strong> Mojo grade upgraded to Hold on improved technicals and financial trends</p>\n <p><strong>10 Mar:</strong> Bullish momentum confirmed with 3.13% intraday gain closing at Rs.141.50</p>\n <p><strong>13 Mar:</strong> Sharp decline of 4.02% amid broader market weakness</p>\n <p><strong>Week Summary:</strong> Stock ends at Rs.137.45, outperforming Sensex by 5.05%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.137.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-la..." }, { "title": "Ind-Swift Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financial-trends-3882097", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_mojoScore_3882097.png", "date": "2026-03-10 08:16:24", "description": "Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 9 March 2026, is driven by a combination of bullish technical trends, strong quarterly earnings growth, and a more favourable valuation outlook, despite some lingering concerns over long-term fundamentals." }, { "title": "Ind-Swift Laboratories Ltd Sees Bullish Momentum Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-sees-bullish-momentum-amid-technical-upgrades-3881836", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_technicaldot_3881836.png", "date": "2026-03-10 08:01:31", "description": "Ind-Swift Laboratories Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The pharmaceutical and biotechnology company’s shares have surged 3.13% today, closing at ₹141.50, reflecting renewed investor confidence and a positive outlook following recent technical upgrades." }, { "title": "Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3875282", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_mojoScore_3875282.png", "date": "2026-03-06 08:05:32", "description": "Ind-Swift Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 5 March 2026, reflecting a complex interplay of technical indicators, valuation concerns, financial trends, and quality assessments. Despite recent positive quarterly results and strong stock returns, underlying fundamental weaknesses and mixed technical signals have prompted a cautious stance from analysts." }, { "title": "Ind-Swift Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3875154", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_technicaldot_3875154.png", "date": "2026-03-06 08:00:53", "description": "Ind-Swift Laboratories Ltd has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. While some indicators signal bullish tendencies, others suggest caution, resulting in a mildly bullish outlook overall. This article analyses the recent technical developments, key indicator readings, and the stock’s performance relative to broader market benchmarks." }, { "title": "Ind-Swift Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-3862193", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_mojoScore_3862193.png", "date": "2026-02-28 10:10:03", "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date analysis of the company’s standing." } ], "total": 179, "sid": "393806", "stock_news_url": "https://www.marketsmojo.com/news/ind-swift-laboratories-393806" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot", "datetime": "30-Mar-2026", "details": "Please find attached Notice of Postal Ballot", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On March 27 2026", "datetime": "27-Mar-2026", "details": "Outcome of Board Meeting held on March 27 2026", "source": "BSE" }, { "caption": "Intimation Regarding Ecovadis Silver Medal And Global Certification", "datetime": "02-Mar-2026", "details": "Please refer attached pdf.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Ind-Swift Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Sep 11", "dt": "2011-09-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Mar: Stock drops 5.78% amid broad market weakness

4 Mar: Further decline of 8.03% on low volume

5 Mar: Sharp rebound with 8.93% gain supported by technical momentum

6 Mar: Downgrade to Sell and mixed technical signals weigh on price, closing near Rs.137.20

Week Open

Rs.145.45

Week Close

Read full news article

Ind-Swift Laboratories Gains 0.18%: 2 Key Factors Driving the Week

2026-03-14 15:03:05

Key Events This Week

09 Mar: Mojo grade upgraded to Hold on improved technicals and financial trends

10 Mar: Bullish momentum confirmed with 3.13% intraday gain closing at Rs.141.50

13 Mar: Sharp decline of 4.02% amid broader market weakness

Week Summary: Stock ends at Rs.137.45, outperforming Sensex by 5.05%

Week Open

Rs.137.20

Read full news article

Ind-Swift Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Trends

2026-03-10 08:16:24

Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 9 March 2026, is driven by a combination of bullish technical trends, strong quarterly earnings growth, and a more favourable valuation outlook, despite some lingering concerns over long-term fundamentals.

Read full news article

Ind-Swift Laboratories Ltd Sees Bullish Momentum Amid Technical Upgrades

2026-03-10 08:01:31

Ind-Swift Laboratories Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The pharmaceutical and biotechnology company’s shares have surged 3.13% today, closing at ₹141.50, reflecting renewed investor confidence and a positive outlook following recent technical upgrades.

Read full news article

Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-03-06 08:05:32

Ind-Swift Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 5 March 2026, reflecting a complex interplay of technical indicators, valuation concerns, financial trends, and quality assessments. Despite recent positive quarterly results and strong stock returns, underlying fundamental weaknesses and mixed technical signals have prompted a cautious stance from analysts.

Read full news article

Ind-Swift Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-06 08:00:53

Ind-Swift Laboratories Ltd has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. While some indicators signal bullish tendencies, others suggest caution, resulting in a mildly bullish outlook overall. This article analyses the recent technical developments, key indicator readings, and the stock’s performance relative to broader market benchmarks.

Read full news article

Ind-Swift Laboratories Ltd is Rated Hold

2026-02-28 10:10:03

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date analysis of the company’s standing.

Read full news article

View All News